ImmunityBio raises $75M in registered direct offering of common stock and warrants

ImmunityBio, Inc.

Gross proceeds of ~$75M from sale of 29.0M shares and warrants; warrants exercisable at $3.101 for 5 years.
Offering priced at $2.584 per share plus warrant; expected close April 9, 2025.
If fully exercised, warrants could yield additional ~$90M in gross proceeds.
Single institutional investor; securities offered under existing shelf registration.
Use of proceeds: working capital and support ongoing business operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.